Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Illumina, Inc. (ILMN) Guidance & Earnings Results

On 2026-07-30 Illumina, Inc. raised guidance: "Revenue guidance raised to $4.60-$4.64B; EPS raised to…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

ILMNIllumina, Inc.Follow ILMN — free
Diagnostics & Research · Healthcare
—
Price chart with a free account
Market cap
40.7B
P/E TTM
50.3
Dividend yield
—
52-week
—
Next earnings
29 Oct, in 5 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
30 Jul 26RaisedRevenue guidance raised to $4.60-$4.64B; EPS raised to $5.30-$5.40 · full year
30 Apr 26RaisedFY2026 revenue guidance raised $20M at midpoint to $4.52-4.62B, non-GAAP EPS to $5.15-5.30 · full year
5 Feb 26RaisedFY2026 revenue $4.5B-$4.6B, growth 4%-6% · full year
30 Oct 25RaisedFY2025 revenue decline narrowed to (1.5%)-(0.5%), non-GAAP EPS raised to $4.65-$4.75 · full year
31 Jul 25RaisedFY25 constant currency revenue decline improved to (2.5%)-(0.5%) from (3%)-(1%); Non-GAAP operating margin 22%-22.5% from 21.5%-22%; Non-GAAP diluted EPS $4.45-$4.55 from $4.20-$4.30; includes ~$0.10 benefit from R&D tax deductibility legislation. · full year

Illumina, Inc. — questions

What guidance did Illumina, Inc. give?
On 2026-07-30: "Revenue guidance raised to $4.60-$4.64B; EPS raised to $5.30-$5.40"
When does Illumina, Inc. report earnings?
Illumina, Inc.'s next earnings report is expected on 2026-10-29.

Every figure on this page comes from Illumina, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.